Literature DB >> 3198492

A new macromolecular antitumor antibiotic, C-1027. II. Isolation and physico-chemical properties.

T Otani1, Y Minami, T Marunaka, R Zhang, M Y Xie.   

Abstract

A new macromolecular antibiotic C-1027 was obtained from the broth filtrate of Streptomyces globisporus C-1027 by precipitation with ammonium sulfate, DEAE-cellulose column chromatography and gel filtration chromatography on a Sephadex G-75 column. This antibiotic, prepared as a white powder, is an acidic polypeptide having an isoelectric point of pH 3.5-3.7 and a molecular weight of 15,000 as determined by SDS-polyacrylamide gel electrophoresis and gel filtration chromatography. The acid hydrolysate of the purified antibiotic C-1027 contained no methionine or tryptophan. From the physico-chemical data, it may be considered to possess a very labile non-protein chromophore.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198492     DOI: 10.7164/antibiotics.41.1580

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  11 in total

1.  Mitotic cell death in BEL-7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication.

Authors:  Yue-Xin Liang; Wei Zhang; Dian-Dong Li; Hui-Tu Liu; Ping Gao; Yi-Na Sun; Rong-Guang Shao
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

2.  Fijiolides A and B, inhibitors of TNF-alpha-induced NFkappaB activation, from a marine-derived sediment bacterium of the genus Nocardiopsis.

Authors:  Sang-Jip Nam; Susana P Gaudêncio; Christopher A Kauffman; Paul R Jensen; Tamara P Kondratyuk; Laura E Marler; John M Pezzuto; William Fenical
Journal:  J Nat Prod       Date:  2010-06-25       Impact factor: 4.050

3.  Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule.

Authors:  Yun-Hong Huang; Bo-Yang Shang; Yong-Su Zhen
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

4.  Pharmacokinetics of C-1027 in mice as determined by TCA-RA method.

Authors:  You-Ping Liu; Quan-Sheng Li; Yu-Rong Huang; Mao-Jin Zhou; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

5.  Tissue distribution and excretion of 125I-lidamycin in mice and rats.

Authors:  You-Ping Liu; Quan-Sheng Li; Yu-Rong Huang; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

6.  Large scale production and semi-purification of kedarcidin in a 1000-L fermentor.

Authors:  K S Lam; D R Gustavson; J M Veitch; S Forenza; J Ross; D Miller; J Roach; W B Lebherz; K Poole
Journal:  J Ind Microbiol       Date:  1994-11

7.  Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells.

Authors:  Y J Xu; D D Li; Y S Zhen
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Specificity of the ester bond forming condensation enzyme SgcC5 in C-1027 biosynthesis.

Authors:  Shuangjun Lin; Tingting Huang; Geoff P Horsman; Sheng-Xiong Huang; Xun Guo; Ben Shen
Journal:  Org Lett       Date:  2012-04-20       Impact factor: 6.005

9.  Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.

Authors:  Qing Zhang; Xiujun Liu; Shuangshuang Xu; Caihong Li; Yang Zhang; Jie Yang; Junnian Zheng
Journal:  Cancer Biother Radiopharm       Date:  2012-05-31       Impact factor: 3.099

10.  Characterization of the SgcF epoxide hydrolase supporting an (R)-vicinal diol intermediate for enediyne antitumor antibiotic C-1027 biosynthesis.

Authors:  Shuangjun Lin; Geoffrey P Horsman; Yihua Chen; Wenli Li; Ben Shen
Journal:  J Am Chem Soc       Date:  2009-11-18       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.